Qatar healthcare market: size, growth and outlook 2026–2032
Public-led, high-spend, now opening to private capacity under the mandatory insurance law. Sized from published research with a GCC and India lens, for buyers, suppliers and investors.
Published 03 Nov 2026Updated 03 Nov 2026Forecast 2026–2032Base year 2025Report code CW-MI-QAT
Public-led, high-spend, now opening to private capacity under the mandatory insurance law. Published estimates normalised to 2025 range from USD 6.0 bn to USD 13.9 bn; the Consulting Wallah central estimate is USD 7.0 bn, growing at about 9% a year to USD 12.8 bn by 2032. Scope differences between publishers explain most of the spread — the comparison table below states each one.
Growth is driven by rising public health budgets: QAR 22 bn (~USD 6 bn) in 2025, ~10.5% of public expenditure; government funds ~70% of health spend; high NCD burden: NCDs cause ~72% of deaths; >400,000 adults with diabetes (nearly a quarter of adults); national Health Strategy 2024-2030 and NDS-3 (2024-30) prioritising private participation and medical tourism under Qatar National Vision 2030.
Context that matters for buyers and suppliers: Qatar has ~25 hospitals (15 public, 10 private), ~5,000 beds and ~57,000 medical and nursing staff; public sector handles ~10 m visits/year. HMC operates a network of 15 hospitals; its 15-year master plan aims to double hospital beds and operating theatres by 2030. Government health spending ~70% of total; 2024 budget QAR 17 bn+ to health institutions and programmes. Physician density ~1.6 per 1,000; nurses ~4.7 per 1,000; >90% of medical staff expatriate.
Market size and forecast
The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 6.0 bn–USD 13.9 bn; differences are mostly scope.
Qatar healthcare market, USD bn. Dark bars reconstructed from the central estimate; 2025 onward Consulting Wallah estimate. Sources listed below.
Alpen Capital (via Gulf Times) (2025-05) — region - GCC current health expenditure; Qatar-specific CAGR
GCC CHE USD 109.1 bn (2024)
GCC CHE USD 159 bn (2029)
Qatar CHE 8.3% (GCC 7.8%)
BMI (via Oxford Business Group) (2024) — country - Qatar domestic health spending
QAR 21.1 bn (USD 5.8 bn) fiscal health outlay (2023)
USD 11 bn domestic health spending (2028)
5.2% (5-year)
Consulting Wallah central estimate
USD 7.0 bn (2025)
USD 12.8 bn (2032)
~9%
Source: Publisher pages as listed under Sources; CW estimate as described in Method.
Scope and definitions
Included: public and private hospital, clinic, diagnostic and long-term care services and the associated health expenditure. Excluded: pharmaceutical and device product sales, insurance premiums and health IT (covered in separate reports). Published totals differ mainly by whether products and insurance are folded in.
Segmentation analysis
Shares as reported by the named sources; ranking is more reliable than the exact percentage.
QAR 22 bn (~USD 6 bn), ~10.5% of public expenditure
2025
Middle East Briefing
Qatar 2024 health budget
QAR 22.1 bn (USD 6.1 bn), 11% of public expenditure
2024
Oxford Business Group
Qatar health expenditure per capita
USD 1,827 (highest in GCC)
2024 report
Oxford Business Group
Qatar hospital bed capacity
~5,000 beds; 25 hospitals (15 public, 10 private)
2025
Qatar Tribune / MoPH
Qatar hospital beds (QNB projection)
3,800 (2018) rising to 5,700 by 2033; 16.3 beds per 10,000 vs OECD 47.9
2019
Qatar Tribune / QNB
GCC current health expenditure
USD 109.1 bn (2024) to USD 159 bn (2029); 12,317 new beds needed; total 140,572 beds
2024-2029
Alpen Capital via Gulf Times
Qatar health & social work GDP contribution
QAR 13.4 bn (USD 3.7 bn), 1.6% of GDP
2022
Oxford Business Group
Source: Sources as named; see Sources and method.
Key facts and context
Qatar has ~25 hospitals (15 public, 10 private), ~5,000 beds and ~57,000 medical and nursing staff; public sector handles ~10 m visits/year (Qatar Tribune / MoPH, Nov 2025)
HMC operates a network of 15 hospitals; its 15-year master plan aims to double hospital beds and operating theatres by 2030 (OBG; US ITA Country Commercial Guide)
Government health spending ~70% of total; 2024 budget QAR 17 bn+ to health institutions and programmes (Nexdigm)
Physician density ~1.6 per 1,000; nurses ~4.7 per 1,000; >90% of medical staff expatriate (Middle East Briefing)
Mandatory expatriate health insurance: employers must buy basic cover from approved Qatari insurers; fine up to QAR 30,000 for passing cost to workers; visitor insurance QAR 50/month (Oxford Business Group 2024)
Qatar Healthcare Facilities Master Plan targets 48 new facilities incl. primary care centres, diagnostic centres, hospital expansions (US ITA Country Commercial Guide)
NHS-2 (2018-22) achieved 90% of goals; all but 1% of targeted treatments now available domestically (Oxford Business Group 2024)
Public provider recorded >1.35 m outpatient visits in H1 2025; PHCC outpatient visits exceeded 1.8 m in 2024 (MarkNtel; Nexdigm)
Three private hospitals tendered on government land (Abu Hamour 150 and 60 beds; Al Shamal 100 beds) at QAR 1/sqm for 25 years (Qatar Tribune / QNB, 2019)
GCC and India outlook
Where the GCC and India sit
Qatar 2025 health budget: QAR 22 bn (~USD 6 bn), ~10.5% of public expenditure (2025) — Middle East Briefing
Qatar 2024 health budget: QAR 22.1 bn (USD 6.1 bn), 11% of public expenditure (2024) — Oxford Business Group
Qatar health expenditure per capita: USD 1,827 (highest in GCC) (2024 report) — Oxford Business Group
Qatar hospital beds (QNB projection): 3,800 (2018) rising to 5,700 by 2033; 16.3 beds per 10,000 vs OECD 47.9 (2019) — Qatar Tribune / QNB
GCC current health expenditure: USD 109.1 bn (2024) to USD 159 bn (2029); 12,317 new beds needed; total 140,572 beds (2024-2029) — Alpen Capital via Gulf Times
Consulting Wallah works this market from both sides: hospital groups in the UAE, Saudi Arabia, India and Bangladesh as buyers, and manufacturers in India, China, Singapore, Malaysia and the US as suppliers through the Network. Our observation is that registration status, in-country stock and structured quotations decide access in the GCC, while price and distributor reach decide it in India. CW observation
Opportunities we see: pPP hospitals: 12 major PPP hospitals operational/under construction, 1,200 new beds, QAR 8 bn private capital committed; digital health/telemedicine: PHCC+HMC teleconsultations rose from ~150,000 (2022) to >220,000 (2023); Naraakom app 1.1 m users; 10 additional hospitals plus clinics planned by MoPH (Nov 2025) alongside 2026 public insurance launch.
Market dynamics
Growth drivers
Rising public health budgets: QAR 22 bn (~USD 6 bn) in 2025, ~10.5% of public expenditure; government funds ~70% of health spend
High NCD burden: NCDs cause ~72% of deaths; >400,000 adults with diabetes (nearly a quarter of adults)
National Health Strategy 2024-2030 and NDS-3 (2024-30) prioritising private participation and medical tourism under Qatar National Vision 2030
Mandatory health insurance for expatriates (Law No. 22 of 2021, announced 2022) and new public health insurance system planned for 2026
Expatriate-heavy population (~3 m, 88% expatriates) and growing demand for specialised care; HMC master plan to double beds by 2030
Restraints
Skilled workforce shortage: 35% of HMC physician vacancies unfilled (mid-2024); >90% of healthcare workforce are non-nationals
Regulatory/licensing delays: average licence processing rose from 60 days (2022) to 75 days (2023)
High operating costs for private facilities and heavy reliance on imported medical supplies/equipment
Low bed density (16.3 per 10,000 vs OECD 47.9) and small population limiting scale
Outbound treatment: ~53,000 Qataris applied for treatment abroad in 2023, exceeding inbound medical tourism
Opportunities
PPP hospitals: 12 major PPP hospitals operational/under construction, 1,200 new beds, QAR 8 bn private capital committed
Digital health/telemedicine: PHCC+HMC teleconsultations rose from ~150,000 (2022) to >220,000 (2023); Naraakom app 1.1 m users
10 additional hospitals plus clinics planned by MoPH (Nov 2025) alongside 2026 public insurance launch
Specialised centres (cardiology, oncology, rehabilitation, mental health, geriatrics) and AI/robotic surgery
Biotech/precision health: QAR 20 bn (USD 5.47 bn) earmarked for biotech, AI and future tech; Qatar Genome Program
Challenges
Delayed implementation of mandatory expatriate insurance law (still not implemented as of 2024 OBG report)
Specialty imbalances and integration of health and social care flagged for NHS-3
IT and data-integration gaps across public and private providers
Fiscal dependence on hydrocarbon revenues for ~70% government-funded system
Appointment delays in public sector (~10 m public visits/year) prompting ministerial reforms
Recent developments
Date
Development
Source
2025-11
MoPH minister announces new public health insurance system to launch in 2026, plus 10 additional hospitals and review of 1980s health laws
Qatar Tribune
2025-10
Qatar 2025 budget allocates QAR 22 bn to health; QAR 20 bn earmarked for biotech/AI; new specialist (cancer, psychiatric) hospitals under construction in Doha and Al Wakrah
Fitch Solutions projects Qatar health spending to grow 14% CAGR to USD 11.5 bn by 2029
The Peninsula Qatar
2025-05
Alpen Capital GCC Healthcare report: Qatar CHE to grow 8.3% CAGR to 2029; GCC needs 12,317 new beds
Gulf Times
2024-02
Military Medical City Hospital opened (400 patient rooms, 36 ICU rooms, 10 operating rooms)
Oxford Business Group
Source: Company and press announcements as named.
Competitive landscape
Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.
Hamad Medical Corporation (HMC) - 15 hospitalsPrimary Health Care Corporation (PHCC)Sidra Medicine (parastatal tertiary women & children)Al Ahli HospitalAl Emadi HospitalDoha Clinic HospitalThe View Hospital (Cedars-Sinai affiliated)American Hospital ClinicsTurkish Hospital DohaAster DM Healthcare (Qatar)Naseem HealthcareCuban Hospital (HMC-run)Military Medical City HospitalAtlas Medical CenterApollo Clinic QatarFuture Medical CenterSurgi Art HospitalWeill Cornell Medicine-Qatar
What it means for you
Operators and investors: capacity, payer rules and licensing timelines decide returns; design central procurement and insurer contracting into the operating model before opening.
Suppliers: registration, a local partner and payer-formulary presence are the gates; central tenders reward structured quotations and reliable supply over the lowest price.
Hospital leaders: payer pressure makes the 25–35% of cost in supplies the margin lever — see the free executive assessment.
Frequently asked questions
How big is the Qatar healthcare market?
Published estimates normalised to 2025 range from USD 6.0 bn to USD 13.9 bn. Consulting Wallah’s central estimate is USD 7.0 bn in 2025, rising to about USD 12.8 bn by 2032.
What is the growth rate?
Published CAGRs range from 5.2% to 13.6%; our central case is about 9% a year to 2032.
Which companies lead?
Hamad Medical Corporation (HMC) - 15 hospitals, Primary Health Care Corporation (PHCC), Sidra Medicine (parastatal tertiary women & children), Al Ahli Hospital, Al Emadi Hospital, Doha Clinic Hospital, The View Hospital (Cedars-Sinai affiliated), American Hospital Clinics among others.
Is the full report free?
The summary on this page is free to read and share with attribution. The full report is free for hospital leaders and registered Consulting Wallah Network members, and priced on request for others.
Middle East Briefing (Dezan Shira) (2025-10) — QAR 22 bn (~USD 6 bn) 2025 health budget (2025) to USD 12.9 bn total health expenditure (2029), CAGR 13.6%; scope: country - Qatar total health expenditure forecast; medtech 5.6% CAGR to 2030; pharma to USD 1.8 bn at 3.1%/yr — source
BMI (via Oxford Business Group) (2024) — QAR 21.1 bn (USD 5.8 bn) fiscal health outlay (2023) to USD 11 bn domestic health spending (2028), CAGR 5.2% (5-year); scope: country - Qatar domestic health spending — source
Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.
Request the full report
The full report (PDF, 40 pages) adds the GCC and India deep-dives, hospital-level benchmarks from the Consulting Wallah Network and the full source tables. Free for hospital leaders and registered network members; otherwise priced on request.
How to read these figures. Published market-size estimates for this market vary widely because publishers define scope differently (software only vs software + services + logistics). Where we show a Consulting Wallah estimate we state the range of published figures it is triangulated from and our scope. Figures marked as reported are quoted from the named source. Nothing here is investment advice.
Want this applied to your hospital or group?Free executive assessment — spend snapshot, benchmark and opportunity brief. Four slots a month.